1 code implementation • 28 Nov 2023 • Jean Ogier du Terrail, Quentin Klopfenstein, Honghao Li, Imke Mayer, Nicolas Loiseau, Mohammad Hallal, Michael Debouver, Thibault Camalon, Thibault Fouqueray, Jorge Arellano Castro, Zahia Yanes, Laetitia Dahan, Julien Taïeb, Pierre Laurent-Puig, Jean-Baptiste Bachet, Shulin Zhao, Remy Nicolle, Jérome Cros, Daniel Gonzalez, Robert Carreras-Torres, Adelaida Garcia Velasco, Kawther Abdilleh, Sudheer Doss, Félix Balazard, Mathieu Andreux
External control arms (ECA) can inform the early clinical development of experimental drugs and provide efficacy evidence for regulatory approval.
1 code implementation • 25 Feb 2020 • Imke Mayer, Julie Josse, Félix Raimundo, Jean-Philippe Vert
Inferring causal effects of a treatment, intervention or policy from observational data is central to many applications.
2 code implementations • 23 Oct 2019 • Imke Mayer, Erik Sverdrup, Tobias Gauss, Jean-Denis Moyer, Stefan Wager, Julie Josse
We find, however, that doubly robust modifications of standard methods for average treatment effect estimation with missing data repeatedly perform better than their non-doubly robust baselines; for example, doubly robust generalized propensity score methods beat inverse-weighting with the generalized propensity score.
Methodology 93C41, 62G35, 62F35, 62P10